Temasek Holdings’s Guardant Health GH Stock Holding History

Temasek Holdings’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154M	Buy	1,023,927 +38,356	+4%	+$4.17M	0.41%	51
2026 Q1	$91M	Sell	985,571 -58,526	-6%	-$5.88M	0.3%	62
2025 Q4	$107M	Hold	1,044,097	–	–	0.34%	55
2025 Q3	$65.2M	Hold	1,044,097	–	–	0.23%	63
2025 Q2	$54.3M	Hold	1,044,097	–	–	0.21%	55
2025 Q1	$44.5M	Sell	1,044,097 -517,882	-33%	-$22.3M	0.18%	61
2024 Q4	$47.7M	Sell	1,561,979 -526,215	-25%	-$14.8M	0.19%	51
2024 Q3	$47.9M	Sell	2,088,194 -1,660,908	-44%	-$47M	0.19%	52
2024 Q2	$108M	Sell	3,749,102 -362,070	-9%	-$8.43M	0.5%	37
2024 Q1	$84.8M	Buy	4,111,172 +437,929	+12%	+$9.39M	0.47%	36
2023 Q4	$99.4M	Hold	3,673,243	–	–	0.56%	33
2023 Q3	$109M	Sell	3,673,243 -290,629	-7%	-$10.2M	0.65%	33
2023 Q2	$142M	Buy	3,963,872 +299,510	+8%	+$8.6M	0.82%	29
2023 Q1	$85.9M	Buy	3,664,362 +2,043,573	+126%	+$58.4M	0.51%	34
2022 Q4	$44.1M	Hold	1,620,789	–	–	0.26%	43
2022 Q3	$87.2M	Buy	1,620,789 +7,782	+0.5%	+$400K	0.52%	36
2022 Q2	$65.1M	Hold	1,613,007	–	–	0.36%	39
2022 Q1	$107M	Hold	1,613,007	–	–	0.45%	37
2021 Q4	$161M	Hold	1,613,007	–	–	0.58%	36
2021 Q3	$202M	Hold	1,613,007	–	–	0.71%	34
2021 Q2	$200M	Hold	1,613,007	–	–	0.67%	30
2021 Q1	$246M	Hold	1,613,007	–	–	0.96%	24
2020 Q4	$208M	Hold	1,613,007	–	–	0.89%	24
2020 Q3	$180M	Hold	1,613,007	–	–	0.92%	22
2020 Q2	$131M	Hold	1,613,007	–	–	0.78%	21
2020 Q1	$112M	Hold	1,613,007	–	–	0.83%	20
2019 Q4	$126M	Hold	1,613,007	–	–	0.82%	22
2019 Q3	$103M	Hold	1,613,007	–	–	0.75%	25
2019 Q2	$139M	Hold	1,613,007	–	–	1%	23
2019 Q1	$124M	Hold	1,613,007	–	–	0.86%	22
2018 Q4	$60.6M	Buy	+1,613,007	New	+$59.4M	0.42%	34

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Temasek Holdings's GH Position: Q2 2026 in Review

Temasek Holdings increased its Guardant Health (GH) stake by 3.9% in Q2 2026, buying an estimated $4.17M and bringing the position to 1,023,927 shares worth $154M. The position accounts for 0.41% of the portfolio, ranked #51.

Temasek Holdings first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $246M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Temasek Holdings held 1,023,927 shares of Guardant Health worth $154M as of Q2 2026.
Temasek Holdings bought 38,356 Guardant Health shares in Q2 2026, an estimated $4.17M.
Guardant Health made up 0.41% of Temasek Holdings's portfolio in Q2 2026, its #51 holding.
Temasek Holdings first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
Temasek Holdings's Guardant Health position peaked at $246M in Q1 2021.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Temasek Holdings's 13F filing for Q2 2026, filed 7 Aug 2026.